# US 2012/0252004 A1 · Highly sensitive immunochromatography method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252004 A1
- Document ID: US20120252004A1
- Status: Published application
- Kind: A1
- Application number: 13/419,153
- Filed: 2012-03-13
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: FUJIFILM Corporation
- Inventors: Atsuhiko WADA; Junichi KATADA
- Web page: https://patentgrep.com/patent/US20120252004A1

## CPC

- G01N 33/54388: {based on lateral flow}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided is an immunochromatography method that enables highly sensitive detection by reducing the background density of a non-measurement site in the immunochromatography method. The immunochromatography method includes developing a complex of a substance to be tested and a labeling substance containing a metal modified with a first binding substance for the substance to be tested on an insoluble carrier in the presence of a surfactant having a steroid skeleton while the substance to be tested and the labeling substance form the complex; and detecting the complex of the substance to be tested by capturing the substance to be tested and the labeling substance on a detection site of the insoluble carrier containing a second binding substance for the substance to be tested or a substance that can bind to the first binding substance for the substance to be tested.

## Claims

### Claim 1

An immunochromatography method comprising:
developing a complex of a substance to be tested and a labeling substance containing a metal modified with a first binding substance for the substance to be tested on an insoluble carrier in the presence of a surfactant having a steroid skeleton while the substance to be tested and the labeling substance form the complex; and
detecting the substance to be tested by capturing the complex of the substance to be tested and the labeling substance in a detection site on the insoluble carrier containing a second binding substance for the substance to be tested or a substance that can bind to the first binding substance for the substance to be tested.

### Claim 2 (depends on 1)

The immunochromatography method according to claim 1,
wherein the surfactant having a steroid skeleton is N,N-bis(3-D-gluconamidopropyl)cholamide (BIGCHAP), 3-[(3-cholamidopropyl)dimethylammonio]propanesulfonate (CHAPS), or deoxycholic acid.

### Claim 3 (depends on 1)

The immunochromatography method according to claim 1,
wherein a solution which contains the substance to be tested and the surfactant and in which the surfactant concentration is 0.05% by mass to 10% by mass is developed on the insoluble carrier.

### Claim 4 (depends on 2)

The immunochromatography method according to claim 2,
wherein a solution which contains the substance to be tested and the surfactant and in which the surfactant concentration is 0.05% by mass to 10% by mass is developed on the insoluble carrier.

### Claim 5 (depends on 1)

The immunochromatography method according to claim 1,
wherein the insoluble carrier is a porous carrier.

### Claim 6 (depends on 2)

The immunochromatography method according to claim 2,
wherein the insoluble carrier is a porous carrier.

### Claim 7 (depends on 3)

The immunochromatography method according to claim 3,
wherein the insoluble carrier is a porous carrier.

### Claim 8 (depends on 1)

The immunochromatography method according to claim 1,
wherein the labeling substance containing a metal is a metallic colloid.

### Claim 9 (depends on 2)

The immunochromatography method according to claim 2,
wherein the labeling substance containing a metal is a metallic colloid.

### Claim 10 (depends on 3)

The immunochromatography method according to claim 3,
wherein the labeling substance containing a metal is a metallic colloid.

### Claim 11 (depends on 8)

The immunochromatography method according to claim 8,
wherein the metallic colloid is a gold colloid.

### Claim 12 (depends on 1)

The immunochromatography method according to claim 1,
wherein the first binding substance is an antibody, and/or the second binding substance is an antibody.

### Claim 13 (depends on 2)

The immunochromatography method according to claim 2,
wherein the first binding substance is an antibody, and/or the second binding substance is an antibody.

### Claim 14 (depends on 3)

The immunochromatography method according to claim 3,
wherein the first binding substance is an antibody, and/or the second binding substance is an antibody.

### Claim 15 (depends on 1)

The immunochromatography method according to claim 1,
wherein after the capturing of the substance to be tested and the labeling substance in detection sites on the insoluble carrier containing the second binding substance for the substance to be tested or a substance that can bind to the first binding substance for the substance to be tested, the substance to be tested is detected by amplifying the captured labeling substance.

### Claim 16 (depends on 2)

The immunochromatography method according to claim 2,
wherein after the capturing of the substance to be tested and the labeling substance in detection sites on the insoluble carrier containing the second binding substance for the substance to be tested or a substance that can bind to the first binding substance for the substance to be tested, the substance to be tested is detected by amplifying the captured labeling substance.

### Claim 17 (depends on 3)

The immunochromatography method according to claim 3,
wherein after the capturing of the substance to be tested and the labeling substance in detection sites on the insoluble carrier containing the second binding substance for the substance to be tested or a substance that can bind to the first binding substance for the substance to be tested, the substance to be tested is detected by amplifying the captured labeling substance.

### Claim 18

An immunochromatography kit comprising:
a labeling substance containing a metal modified with a first binding substance for a substance to be tested;
an insoluble carrier containing a second binding substance for the substance to be tested or a substance having a detection site that can bind to the first binding substance for the substance to be tested; and
a surfactant having a steroid skeleton.
